
Proteasome inhibitorIndian prescription status not found in lists checkedOn NLEM 2022NPPA price ceilingJan Aushadhi listed
Bortezomib
बोर्टेज़ोमिब
This page covers the injection (intravenous, subcutaneous) form only, as described in the US label. Other forms of bortezomib sold in India may differ.
Bortezomib for injection is a proteasome inhibitor. The label describes it for adults with multiple myeloma and mantle cell lymphoma. It is given into a vein or under the skin and must never be given into the spinal canal, which can be fatal.
- Generic name
- Bortezomib
- Used for
- Treatment of adults with multiple myeloma and mantle cell lymphoma, by injection.
- Label used
- Injection label, intravenous, subcutaneous, DailyMed set b605b541, effective 2026-09
- Prescription status (India)
- Not found in the Schedule H/H1/X/G lists we checked
- On NLEM 2022
- Yes (Powder for Injection 2 mg)
- NPPA price ceiling
- Yes (scheduled formulation)
More facts
- Jan Aushadhi
- Listed (3 product rows)
- Banned combinations
- None found in the list we checked
Compiled from official drug labels and Indian government sources. Always follow your doctor's or pharmacist's advice.
Safety at a glance
- AlcoholNot mentioned in label text
- PregnancyCaution in label textSee wording
- BreastfeedingCaution in label textSee wording
- DrivingNot mentioned in label text
- KidneyNot mentioned in label text
- LiverCaution in label textSee wording
Taken only from the label text cited on this page. "Not mentioned" does not mean safe. Ask your doctor or pharmacist.
What is bortezomib used for?
The label describes bortezomib for injection for adults with multiple myeloma and for adults with mantle cell lymphoma.
- Multiple myeloma in adults
- Mantle cell lymphoma in adults
It treats two blood cancers in adults.
Source1
How does bortezomib work?
The label says bortezomib reversibly blocks the 26S proteasome, a protein complex that breaks down proteins inside cells.
Blocking it disrupts normal cell balance and can lead to cell death, including in cancer cells.
It blocks a cell protein-disposal system, which can kill cancer cells.
Source1
How is bortezomib usually taken?
This page covers the injection label only (route: intravenous, subcutaneous). Dosing for other forms differs, and the prescriber decides which one you use.
This is label-level information, not personal advice. Indian pack labels may differ, and your prescriber's instruction always comes first.
This page covers the injection form. The label says it is for intravenous or subcutaneous use only, and each route uses a different concentration, so the volume must be calculated carefully.
The label describes a starting dose based on body surface area, given as a quick intravenous injection or a subcutaneous injection, in treatment cycles. It advises a lower starting dose in moderate or severe liver impairment.
The label we reviewed does not describe oral dosing for this medicine.
- Given by a healthcare professional
- Into a vein or under the skin only
- Never into the spinal canal (intrathecal)
- Lower starting dose in liver impairment
It is given by injection by a healthcare professional, in cycles.
Source1
What are the side effects of bortezomib?
Common
- The label lists common effects including nausea, diarrhoea, low platelets, low white cells, nerve damage in hands and feet, tiredness, anaemia, constipation, vomiting, rash, fever and loss of appetite.
- Nausea, vomiting, diarrhoea
- Low blood counts
- Numbness, pain or burning in hands or feet
- Tiredness and fever
- Low blood pressure
Serious: get help
- Serious effects described include low blood pressure, heart problems, lung problems, liver problems, tumour lysis syndrome and a brain condition called PRES.
Common effects include stomach upset, low blood counts and nerve problems.
Source1
Who should be careful with bortezomib?
The label says it must not be used in people hypersensitive to bortezomib, boron or mannitol, and never by the intrathecal route.
It warns about nerve damage, low blood pressure, heart and lung toxicity, bleeding risk from low platelets, liver toxicity and tumour lysis syndrome. Blood counts and liver enzymes are monitored.
It can cause fetal harm. The label advises effective contraception for women and for men with partners who could become pregnant.
- Not for intrathecal use, which has been fatal
- Not for those allergic to bortezomib, boron or mannitol
- Nerve damage may worsen existing neuropathy
- Caution with low blood pressure, dehydration or heart disease
- Can harm an unborn baby
It needs close monitoring of nerves, blood counts, heart and liver.
Source1
What medicines interact with bortezomib?
- Strong CYP3A4 inducers: avoid
- Strong CYP3A4 inhibitors: monitor closely
- Antihypertensives: caution for low blood pressure
- The label says strong CYP3A4 inducers lower bortezomib levels and should be avoided.
- Strong CYP3A4 inhibitors raise levels and need close monitoring.
- No clinically significant interactions were seen with dexamethasone, omeprazole, or melphalan with prednisone.
No match in this label text. Ask your pharmacist about any medicine you take.
Medicines that change CYP3A4 can alter its effect.
Source1
How should bortezomib be stored?
The label gives a storage range of 20 to 25 degrees C.
The label also says to protect it from light.
Follow the storage line on your own pack, and keep medicines out of the reach of children.
Follow the storage instructions on your pack.
Source1
Is bortezomib a prescription medicine in India?
We did not find bortezomib in the Drugs Rules 1945 Schedule H, H1, X or G rows we checked, so we cannot state its Indian prescription status from our lists. Ask your pharmacist or doctor.
Bortezomib is on the National List of Essential Medicines 2022. Listed forms include: Powder for Injection 2 mg (page 81).
NPPA lists ceiling prices for scheduled bortezomib formulations. The table shows the rows we found. Check NPPA directly for the current list.
The Jan Aushadhi (PMBJP) list we checked has 3 product rows that mention bortezomib. We did not capture prices for them.
| List | Formulation and strength | Unit | Ceiling price (Rs) |
|---|---|---|---|
| Anti-cancer, as on March, 2026, page 3 | Powder for Injection 2mg | 1 Vial | 5386.81 |
| All scheduled (NLEM 2015), as on 30.09.2020, page 3 | Powder for Injection 2 mg | Each Pack | 12263.10 |
We did not find bortezomib in the Schedule H, H1, X or G rows we checked, on NLEM 2022 and with NPPA price ceilings.
What is the price ceiling for bortezomib?
NPPA ceiling prices set the most a seller can charge per unit for the listed formulations, before local taxes. They are ceilings, not the price you will always pay.
Jan Aushadhi lists bortezomib products including Bortezomib Injection IP 3.5 mg 3.5 mg; Bortezomib 2mg powder for Injection 2mg; Bortezomib 2.5mg powder for Injection 2.5mg. We have not shown a price for them. Check the pack and the seller for the actual price.
NPPA lists per-unit ceilings where a formulation is scheduled. Check the pack and seller.
Frequently asked questions
Can I drink alcohol while taking bortezomib?
The label we reviewed does not say. Ask your doctor or pharmacist.
Source1
Is bortezomib safe in pregnancy and breastfeeding?
The label says bortezomib can cause fetal harm and advises effective contraception. Breastfeeding is not covered here. Ask your doctor or pharmacist.
Source1
Should bortezomib be taken with food?
This is an injection given by a professional, so food is not part of its use. Ask your doctor or pharmacist.
Source1
Can bortezomib affect driving or alertness?
The label we reviewed does not say. It lists tiredness and low blood pressure as possible effects. Ask your doctor or pharmacist.
Source1
Can children or older adults take bortezomib?
The label describes use in adult patients. The label we reviewed does not say more. Ask your doctor or pharmacist.
Source1
Sources
- 1U.S. FDA-approved label (DailyMed) (b605b541-4bfd-db3e-9710-11c27f6dee6c) Open source · 2026-10-15
- 2National List of Essential Medicines 2022 (81) Open source · 2026-10-15
- 3NPPA price ceiling list (Anti-cancer 3) Open source · 2026-10-15
- 4PMBJP (Jan Aushadhi) product list (p25:sno563) Open source · 2026-10-15
Compiled by software from the sources above and checked by automated rules. Last checked: 2026-10-15 · How we use sources · Report a correction
This information is educational and is not a substitute for advice from your doctor or pharmacist. It does not tell you what dose you personally should take. In an emergency call 112.